Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 12/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.44 |
| ▸ | IARS1 | P41252 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11138852 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL6849597 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL1770627 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL196353 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL1770623 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL14904584 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| SCHEMBL2059099 | 1.00 | DPP4 (0.44) | DPP4DPP8DPP9IARS1CA1 | |
| Hydrochloric Acid SCHEMBL5420866 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9IARS1CA1 | |
| Hydrochloric Acid SCHEMBL4284558 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9IARS1CA1 | |
| Hydrochloric Acid SCHEMBL233325 | 0.98 | DPP4 (0.43) | DPP4DPP8DPP9IARS1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1049 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098018-A1 | BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF | CYTOKINETICS INC (US) | 2026-04-09 | — | — | US | claimed |
| CN-119899137-A | Method for preparing Fmoc-Ile-OH by chemical derivatization | 杭州湃肽生化科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119874660-A | Amino acid derivative-rhodamine B conjugate, preparation method thereof and application thereof as fluorescent tracer | 内蒙古农业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119569652-A | 2,2 '-Biquinoline-4, 4' -dicarboxylic acid aliphatic amino acid derivative, preparation and application thereof | 武汉大学人民医院（湖北省人民医院） | 2025-03-07 | — | — | CN | claimed |
| CN-119504883-A | Synthesis method of RNA monomer intermediate 2' -fluoro-nucleoside modifier | 安徽信佰生物医药科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119409588-A | Caffeoyl amino acid methyl ester derivative and preparation method and application thereof | 西北大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119409587-A | Amino acid derivative of 2,2 '-binaphthyl-6, 6' -dicarboxylic acid, and preparation method and application thereof | 武汉大学人民医院（湖北省人民医院） | 2025-02-11 | — | — | CN | claimed |
| CN-119241617-A | 2 '-Deoxy-2' -fluoro-N4-substituted cytidine compound, preparation method and application thereof | 河南省科学院高新技术研究中心 | 2025-01-03 | — | — | CN | claimed |
| CN-119176846-A | Baohuoside I carbamate prodrug and salt, preparation and application thereof | 沈阳药科大学 | 2024-12-24 | — | — | CN | claimed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | claimed |
| CN-101368936-A | Method for appraising Holotrichia parallela sex pheromone | SHANDONG PEANUT RES INST (CN) | 2009-02-18 | — | — | CN | claimed |
| CN-101318933-A | Isoquinolinium compounds with antithrombotic activity, preparation method and application thereof | UNIV BEIJING (CN) | 2008-12-10 | — | — | CN | claimed |
| WO-2008094846-A1 | REVERSIBLE ROOM-TEMPERATURE IONIC LIQUIDS | GEORGETOWN UNIVERSITY (US) | 2008-08-07 | — | — | WO | claimed |
| CN-101190895-A | N-[(3S)-1,2,3,4-tetrahydroisoquinolino-3-formacyl]amino acid, preparation method and application thereof | UNIV CAPITAL MEDICAL SCIENCES (CN) | 2008-06-04 | — | — | CN | claimed |
| CN-101084005-A | Compounds for flaviviridae treatment | NOVARTIS AG (CH) | 2007-12-05 | — | — | CN | claimed |
| EP-0397652-B1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | GENZYME CORP (US) | 1996-06-05 | — | — | EP | claimed |
| EP-0397652-A4 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | — | 1991-04-03 | — | — | EP | claimed |
| EP-0397652-A1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID. | GENZYME CORP (US) | 1990-11-22 | — | — | EP | claimed |
| US-4937270-A | Water insoluble derivatives of hyaluronic acid | GENZYME CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| WO-1989002445-A1 | WATER INSOLUBLE DERIVATIVES OF HYALURONIC ACID | GENZYME CORPORATION (US) | 1989-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098018-A1 | BICYCLIC 1,4-DIAZEPANONES AND THERAPEUTIC USES THEREOF | MYLK2, TNNT2, RYR1 | DPP4 997/4885DPP8 2247/4885DPP9 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.